This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Longitude Prize on Antimicrobial Resistance (AMR)
What is the Longitude Prize on Antimicrobial Resistance (AMR) ?
The Longitude Prize is looking for a team of researchers to invent an affordable, accurate, fast and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time. £8 million will be awarded to the winner, to help solve the global problem of antibiotic resistance.
Why are we doing this?
On average, antibiotics add 20 years to each person’s life. The development of antibiotics has been vital to our survival, yet the rise of antimicrobial resistance is threatening to make them ineffective in the future. Point-of-care test kits will allow more targeted use of antibiotics, and an overall reduction in misdiagnosis and prescription. They will form a vital part of the toolkit for stewardship of antibiotics in the future. This will ensure that the antibiotics we have now will be effective for longer and we can continue to control infections during routine and major procedures.
What are we doing?
Currently we are working with and supporting more than 50 competing teams of innovators around the world. We are supporting them with collaboration opportunities, preparing them for market-readiness, profiling, and connecting them with new funding opportunities. The prize is open to new entrants at any point.
The Longitude Prize on Antimicrobial Resistance (AMR)
Where are we now?
The £8 million prize has now closed for entires.
The deadline was extended in 2020 to ensure that the competing teams have enough time to complete development of their rapid point-of-care diagnostic tests that can help slow the development of antimicrobial resistance (AMR).
The Judges
Along with the Longitude Prize’s Advisory Panel the Longitude Committee is responsible for on-going prize consultation and will, ultimately, judge and decide which entry should win.
-
Fiona Carragher
Director of Research & Influencing Alzheimer's Society
-
Indro Mukerjee
CEO of Innovate UK
-
Dame Angela McLean
Government Chief Scientific Adviser
-
Ravi Gurumurthy
Chief Executive Officer, Nesta
-
Gisela Abbam
Chair, British Science Association, Global Goodwill Ambassador & Freelance Consultant
-
Dr Penny Wilson
Senior Specialist, AMR, Vaccines and Global Health